|
ZNF490 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.462700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.896800E-03 |
| Normal-vs-Stage2 |
4.840200E-01 |
| Normal-vs-Stage3 |
5.798900E-03 |
| Normal-vs-Stage4 |
1.079030E-03 |
| Stage1-vs-Stage2 |
6.963600E-02 |
| Stage1-vs-Stage3 |
8.294400E-01 |
| Stage1-vs-Stage4 |
1.688780E-01 |
| Stage2-vs-Stage3 |
6.380300E-02 |
| Stage2-vs-Stage4 |
1.575820E-02 |
| Stage3-vs-Stage4 |
3.012800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.079500E-03 |
| Normal-vs-AfricanAmerican |
4.097500E-02 |
| Normal-vs-Asian |
4.291700E-02 |
| Caucasian-vs-AfricanAmerican |
6.448000E-01 |
| Caucasian-vs-Asian |
4.237800E-01 |
| AfricanAmerican-vs-Asian |
8.901800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.834300E-02 |
| Normal-vs-Female |
3.443000E-03 |
| Male-vs-Female |
1.521360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.698400E-03 |
| Normal-vs-Age(41-60Yrs) |
2.176100E-02 |
| Normal-vs-Age(61-80Yrs) |
8.199000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.560200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.431600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.284800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.328000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.691000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.858600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.179600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.244010E-01 |
| Classical-VS-Follicular |
7.561000E-01 |
| Classical-VS-Other |
2.928800E-01 |
| Classical-VS-Normal |
1.598170E-02 |
| Tall-VS-Follicular |
3.225800E-01 |
| Tall-VS-Other |
6.694000E-01 |
| Tall-VS-Normal |
2.639300E-03 |
| Follicular-VS-Other |
4.101400E-01 |
| Follicular-VS-Normal |
1.959650E-02 |
| Other-VS-Normal |
9.763800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.071600E-02 |
| Normal-vs-N1 |
7.81790000000671E-05 |
| N0-vs-N1 |
3.835300E-04 |
|
|
